Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP329133.RA3Cr1Hdy3gR3Ek4jJXR4V-pSKWCEC3qlopbeLpZw_w4g130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP329133.RA3Cr1Hdy3gR3Ek4jJXR4V-pSKWCEC3qlopbeLpZw_w4g130_assertion type Assertion NP329133.RA3Cr1Hdy3gR3Ek4jJXR4V-pSKWCEC3qlopbeLpZw_w4g130_head.
- NP329133.RA3Cr1Hdy3gR3Ek4jJXR4V-pSKWCEC3qlopbeLpZw_w4g130_assertion description "[SH-SY5Y neuroblastoma with increased MTHFS expression displayed a 4-fold resistance to the GARFT inhibitor LY309887, but did not exhibit resistance to the thymidylate synthase inhibitor Pemetrexed.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP329133.RA3Cr1Hdy3gR3Ek4jJXR4V-pSKWCEC3qlopbeLpZw_w4g130_provenance.
- NP329133.RA3Cr1Hdy3gR3Ek4jJXR4V-pSKWCEC3qlopbeLpZw_w4g130_assertion evidence source_evidence_literature NP329133.RA3Cr1Hdy3gR3Ek4jJXR4V-pSKWCEC3qlopbeLpZw_w4g130_provenance.
- NP329133.RA3Cr1Hdy3gR3Ek4jJXR4V-pSKWCEC3qlopbeLpZw_w4g130_assertion SIO_000772 19022216 NP329133.RA3Cr1Hdy3gR3Ek4jJXR4V-pSKWCEC3qlopbeLpZw_w4g130_provenance.
- NP329133.RA3Cr1Hdy3gR3Ek4jJXR4V-pSKWCEC3qlopbeLpZw_w4g130_assertion wasDerivedFrom befree-20140225 NP329133.RA3Cr1Hdy3gR3Ek4jJXR4V-pSKWCEC3qlopbeLpZw_w4g130_provenance.
- NP329133.RA3Cr1Hdy3gR3Ek4jJXR4V-pSKWCEC3qlopbeLpZw_w4g130_assertion wasGeneratedBy ECO_0000203 NP329133.RA3Cr1Hdy3gR3Ek4jJXR4V-pSKWCEC3qlopbeLpZw_w4g130_provenance.